MapLight Therapeutics Statistics
Total Valuation
MPLT has a market cap or net worth of $806.93 million. The enterprise value is $585.77 million.
| Market Cap | 806.93M |
| Enterprise Value | 585.77M |
Important Dates
The last earnings date was Thursday, December 4, 2025, before market open.
| Earnings Date | Dec 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MPLT has 43.64 million shares outstanding. The number of shares has increased by 15.66% in one year.
| Current Share Class | 40.91M |
| Shares Outstanding | 43.64M |
| Shares Change (YoY) | +15.66% |
| Shares Change (QoQ) | +3.67% |
| Owned by Insiders (%) | 10.57% |
| Owned by Institutions (%) | 3.38% |
| Float | 16.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.46 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.22, with a Debt / Equity ratio of 0.03.
| Current Ratio | 13.22 |
| Quick Ratio | 12.24 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -45.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.63M |
| Employee Count | 63 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 62.15 |
| Average Volume (20 Days) | 265,513 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -108.48M |
| Pretax Income | -102.83M |
| Net Income | -102.83M |
| EBITDA | -107.85M |
| EBIT | -108.48M |
| Earnings Per Share (EPS) | -$133.73 |
Balance Sheet
The company has $227.17 million in cash and $6.01 million in debt, giving a net cash position of $221.16 million or $5.07 per share.
| Cash & Cash Equivalents | 227.17M |
| Total Debt | 6.01M |
| Net Cash | 221.16M |
| Net Cash Per Share | $5.07 |
| Equity (Book Value) | 233.52M |
| Book Value Per Share | -0.45 |
| Working Capital | 226.74M |
Cash Flow
In the last 12 months, operating cash flow was -$112.80 million and capital expenditures -$203,000, giving a free cash flow of -$113.00 million.
| Operating Cash Flow | -112.80M |
| Capital Expenditures | -203,000 |
| Free Cash Flow | -113.00M |
| FCF Per Share | -$2.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MPLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.66% |
| Shareholder Yield | -15.66% |
| Earnings Yield | -12.74% |
| FCF Yield | -14.00% |
Analyst Forecast
The average price target for MPLT is $31.00, which is 67.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.00 |
| Price Target Difference | 67.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |